112 related articles for article (PubMed ID: 10073977)
21. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation.
White AL; Graham DL; LeGros J; Pease RJ; Scott J
J Biol Chem; 1992 Aug; 267(22):15657-64. PubMed ID: 1639804
[TBL] [Abstract][Full Text] [Related]
22. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
23. Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells.
Jin FY; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1051-9. PubMed ID: 10195935
[TBL] [Abstract][Full Text] [Related]
24. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells.
Horie M; Hayashi M; Satoh T; Hotta H; Nagata Y; Ishida F; Kamei T
Biochim Biophys Acta; 1993 May; 1168(1):45-51. PubMed ID: 8504141
[TBL] [Abstract][Full Text] [Related]
25. Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment.
Sato R; Imanaka T; Takatsuki A; Takano T
J Biol Chem; 1990 Jul; 265(20):11880-4. PubMed ID: 2114405
[TBL] [Abstract][Full Text] [Related]
26. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors.
Kempen HJ; Imbach AP; Giller T; Neumann WJ; Hennes U; Nakada N
J Lipid Res; 1995 Aug; 36(8):1796-806. PubMed ID: 7595100
[TBL] [Abstract][Full Text] [Related]
27. Regulation of apolipoprotein B biogenesis in human hepatocytes: posttranscriptional control mechanisms that determine the hepatic production of apolipoprotein B-containing lipoproteins.
Adeli K; Mohammadi A; Macri J
Clin Biochem; 1995 Apr; 28(2):123-30. PubMed ID: 7628070
[TBL] [Abstract][Full Text] [Related]
28. Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion.
Zaiden N; Yap WN; Ong S; Xu CH; Teo VH; Chang CP; Zhang XW; Nesaretnam K; Shiba S; Yap YL
J Atheroscler Thromb; 2010 Oct; 17(10):1019-32. PubMed ID: 20702976
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion.
Borchardt RA; Davis RA
J Biol Chem; 1987 Dec; 262(34):16394-402. PubMed ID: 3680257
[TBL] [Abstract][Full Text] [Related]
30. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
Sakata N; Wu X; Dixon JL; Ginsberg HN
J Biol Chem; 1993 Nov; 268(31):22967-70. PubMed ID: 8226809
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of secretion of truncated apolipoproteins B by monomethylethanolamine is independent of the length of the apolipoprotein.
Rusiñol AE; Vance JE
J Biol Chem; 1995 Jun; 270(22):13318-25. PubMed ID: 7768932
[TBL] [Abstract][Full Text] [Related]
32. Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized HEP G2 cells.
Adeli K; Wettesten M; Asp L; Mohammadi A; Macri J; Olofsson SO
J Biol Chem; 1997 Feb; 272(8):5031-9. PubMed ID: 9030566
[TBL] [Abstract][Full Text] [Related]
33. The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.
Srivastava N; Cefalu AB; Noto D; Schonfeld G; Averna M; Srivastava RA
Biochem Biophys Res Commun; 2010 Aug; 398(4):665-70. PubMed ID: 20609357
[TBL] [Abstract][Full Text] [Related]
34. A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Telford DE; Lipson SM; Barrett PH; Sutherland BG; Edwards JY; Aebi JD; Dehmlow H; Morand OH; Huff MW
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2608-14. PubMed ID: 16210564
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and secretion of VLDL by rat hepatocytes--modulation by cholesterol and phospholipids.
Kumar NS; Abraham R; Kumar GS; Sudhakaran PR; Kurup PA
Indian J Biochem Biophys; 1992 Oct; 29(5):438-41. PubMed ID: 1289236
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of translocation of nascent apolipoprotein B across the endoplasmic reticulum membrane is associated with selective inhibition of the synthesis of apolipoprotein B.
Pan M; Liang Js; Fisher EA; Ginsberg HN
J Biol Chem; 2000 Sep; 275(35):27399-405. PubMed ID: 10846173
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
[TBL] [Abstract][Full Text] [Related]
38. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes.
White AL; Rainwater DL; Lanford RE
J Lipid Res; 1993 Mar; 34(3):509-17. PubMed ID: 8468534
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane.
Ingram MF; Shelness GS
J Lipid Res; 1996 Oct; 37(10):2202-14. PubMed ID: 8906597
[TBL] [Abstract][Full Text] [Related]
40. Intracellular degradation of newly synthesized apolipoprotein B.
Yao Z; Tran K; McLeod RS
J Lipid Res; 1997 Oct; 38(10):1937-53. PubMed ID: 9374117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
